CClinicalTrials.gg
Not yet recruitingNCT07504302Updated Mar 31, 2026

Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital

An observational study in CKD on Hemodialysis Patients, sponsored by Sohag University. Not yet recruiting. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-03-31.

Sponsored by Sohag University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
160
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The aim of this study is to determine the prevalence of anxiety and depression among hemodialysis patients attending Sohag University Hospital and to identify the sociodemographic and clinical factors associated with these psychological disorders.

The study is a descriptive cross-sectional study conducted on patients undergoing maintenance hemodialysis at the Hemodialysis Unit, Sohag University Hospital.

02

Conditions studied

  • CKD on Hemodialysis Patients

Keywords

  • Anxiety
  • Depression
  • hemodialysis patients
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,388 are open to participants now.

This study's planned enrollment of 160 is close to the median of 150 across 606 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

CKD on dialysis patients at Sohag University

Inclusion criteria

  • Patients diagnosed with end-stage renal disease (ESRD) and maintained on regular hemodialysis for at least 3 months.
  • Patients aged more than 18 years old.
  • Patients receiving hemodialysis three sessions per week, each lasting 3-4 hours.
  • Patients who can communicate effectively and are able to complete the required questionnaires.
  • Patients able to provide informed consent.

Exclusion criteria

Exclusion Criteria:

  • Patients suffering from major visual or hearing impairments.
  • Patients with a known psychiatric disorder diagnosed prior to initiation of hemodialysis.
  • Patients receiving psychiatric medications or active psychotherapy.
  • Patients with severe cerebrovascular diseases.
  • Patients with chronic liver diseases, lung diseases or malignancies that can add additional psychological burden.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
160 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • CKD on dialysis patients

    Other: No Interventions

Interventions

  • OtherNo Interventions

    No interventions

06

What researchers measure

Primary outcomes

  1. Questionnaire for the Prevalence of Anxiety and Depression Among Hemodialysis Patients at Sohag University Hospital

    Time frame: From enrollment to the end of treatment at 8 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07504302
Lead sponsor
Sohag University
Responsible party
Norhan Hussien (Principal Investigator Norhan Hussien Abd El-Rheem, Sohag University) — Principal investigator
First posted
Mar 31, 2026
Start date
May 2026 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Mar 31, 2026

Study contacts

Norhan Hussien Abd El-Rheem
Contact
norhanhussein97@gmail.com
+201147088030

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion